The Discounted Cash Flow (DCF) valuation of VIVA Biotech Holdings (1873.HK) is 0.97 HKD. With the latest stock price at 1.86 HKD, the upside of VIVA Biotech Holdings based on DCF is -47.8%.
Based on the latest price of 1.86 HKD and our DCF valuation, VIVA Biotech Holdings (1873.HK) is a sell. selling 1873.HK stocks now will result in a potential gain of 47.8%.
| Range | Selected | |
| WACC / Discount Rate | 7.4% - 11.7% | 9.6% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 0.45 - 2.48 | 0.97 |
| Upside | -76.0% - 33.5% | -47.8% |